-
Biotech
Parallax Diagnostics Announces Intent to Develop a Rapid Screening Test for COVID-19 on its Patented FDA 510(K) Approved Diagnostic Platform
New York, NY – March 11, 2020 – Parallax Health Sciences, Inc.(OTCQB: PRLX) (”Parallax” or the ”Company”), an outcome-driven connected healthcare…
Read More » -
News
Wall Street coronavirus contingency plans
(Reuters) – As the coronavirus spreads in the financial hub of New York, financial firms – led by the Securities…
Read More » -
Biotech
NanoViricides to Produce Broad Spectrum Antiviral Clinical Trial Candidates for COVID-19
The COVID-19 coronavirus is spreading rapidly across the globe despite persistent efforts from Governments to contain its spread.
Read More » -
Featured
Avivagen’s OxC-beta™ Livestock product May Prevent Future Outbreaks Like The Wuhan Coronavirus
The emerging crisis of the Wuhan coronavirus in China has global implications with over 2,126 deaths worldwide and over 75,700…
Read More » -
Biotech
Moderna Gains 18% on positive CMV vaccine data
Moderna (NASDAQ:MRNA) gained 16% in heavy after-hours buying and selling exercise at the moment. The firm posted the positive Phase…
Read More »